| 271 |
Risk of drug resistance and repeated infection with Klebsiella pneumoniae and Escherichia coli in intensive care unit cancer patients |
قسم الاورام الطبية |
2021 |
| 272 |
Risk of drug resistance and repeated infection with Klebsiella pneumoniae and Escherichia coli in intensive care unit cancer patients |
قسم الاورام الطبية |
2021 |
| 273 |
Risk of drug resistance and repeated infection with Klebsiella pneumoniae and Escherichia coli in intensive care unit cancer patients |
قسم الباثولوجيا الإكلينيكية |
2021 |
| 274 |
Risk of drug resistance and repeated infection with Klebsiella pneumoniae and Escherichia coli in intensive care unit cancer patients |
قسم الباثولوجيا الإكلينيكية |
2021 |
| 275 |
Risk of drug resistance and repeated infection with Klebsiella pneumoniae and Escherichia coli in intensive care unit cancer patients |
قسم أورام الأطفال |
2021 |
| 276 |
Risk of drug resistance and repeated infection with Klebsiella pneumoniae and Escherichia coli in intensive care unit cancer patients |
قسم أورام الأطفال |
2021 |
| 277 |
Role of Metastatic Colon Cancer Topography in Pathological and Molecular Variability : A Retrospective Study |
قسم الباثولجى |
2021 |
| 278 |
Role of Metastatic Colon Cancer Topography in Pathological and Molecular Variability : A Retrospective Study |
قسم الباثولجى |
2021 |
| 279 |
Role of Metastatic Colon Cancer Topography in Pathological and Molecular Variability : A Retrospective Study |
قسم الاورام الطبية |
2021 |
| 280 |
Role of Metastatic Colon Cancer Topography in Pathological and Molecular Variability : A Retrospective Study |
قسم الاورام الطبية |
2021 |
